Nutrients from fruit and vegetable consumption reduce the risk of pancreatic cancer

Journal of Gastrointestinal Cancer

Volumn 44, Issue 2, 2013, Pages 152-161

  Jansen, Rick J ^a   Robinson, Dennis P ^a   Stolzenberg Solomon, Rachael Z ^b   Bamlet, William R ^a   De Andrade, Mariza ^a   Oberg, Ann L ^a   Rabe, Kari G ^a   Anderson, Kristin E ^c   Olson, Janet E ^a   Sinha, Rashmi ^d   Petersen, Gloria M ^a  

^a MAYO CLINIC   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Case control; Diet; Fruits; Nutrients; Pancreatic cancer; Vegetables

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; BETA CRYPTOXANTHIN; CRYPTOXANTHIN; LYCOPENE; MAGNESIUM; NICOTINIC ACID; POTASSIUM; PYRIDOXINE; RETINOL; SELENIUM; THIAMINE; XANTHOPHYLL; ZEAXANTHIN;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CALORIC INTAKE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIET; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; FRUIT; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRIENT; PANCREAS CANCER; PANCREATITIS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SMOKING; SUGAR INTAKE; VEGETABLE; ADENOCARCINOMA; DIET SUPPLEMENTATION; PANCREAS TUMOR; QUESTIONNAIRE; RISK; RISK FACTOR;

ADENOCARCINOMA; AGED; CASE-CONTROL STUDIES; DIET; DIETARY SUPPLEMENTS; FEMALE; FRUIT; HUMANS; MALE; ODDS RATIO; PANCREATIC NEOPLASMS; QUESTIONNAIRES; RISK FACTORS; VEGETABLES;

EID: 84886690532     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-012-9441-y     Document Type: Article

References (48)

1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr. Accessed 18 Nov 2011.
2. American Cancer Society. Cancer facts & figures 2012. Atlanta: American Cancer Society; 2012. Accessed 3 Mar 2012.
3. Chari ST. Detecting early pancreatic cancer: problems and prospects. Semin Oncol. 2007;34:284-94.
4. Klapman J, Malafa MP. Early detection of pancreatic cancer: why, who, and how to screen. Cancer Control. 2008;15:280-7.
5. Howe GR, Ghadirian P, Bueno de Mesquita HB, Zatonski WA, Baghurst PA, Miller AB, Simard A, Baillargeon J, de Waard F, Przewozniak K, et al. A collaborative case-control study of nutrient intake and pancreatic cancer within the search programme. Int J Cancer. 1992;51:365-72.
6. Nkondjock A, Ghadirian P, Johnson KC, Krewski D. Dietary intake of lycopene is associated with reduced pancreatic cancer risk. J Nutr. 2005;135:592-7.
7. Olsen GW, Mandel JS, Gibson RW, Wattenberg LW, Schuman LM. Nutrients and pancreatic cancer: a population-based case-control study. Cancer Causes Control. 1991;2:291-7.
8. Ghadirian P, Simard A, Baillargeon J, Maisonneuve P, Boyle P. Nutritional factors and pancreatic cancer in the francophone community in Montreal, Canada. Int J Cancer. 1991;47:1-6.
9. Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, Hartman TJ, Tangrea JA, Rautalahti M, Sehlub J,Virtamo J, Taylor PR. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst. 1999;91:535-41.
10. Foksinski M, Gackowski D, Rozalski R, Siomek A, Guz J, Szpila A, Dziaman T, Olinski R. Effects of basal level of antioxidants on oxidative DNA damage in humans. Eur J Nutr. 2007;46:174-80.
11. Morales E, Porta M, Vioque J, Lopez T, Mendez MA, Pumarega J, Malats N, Crous-Bou M, Ngo J, Rifa J, Carrato A, Guarner L, et al. Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. J Epidemiol Community Health. 2007;61:641-9.
12. Lin Y, Tamakoshi A, Hayakawa T, Naruse S, Kitagawa M, Ohno Y. Nutritional factors and risk of pancreatic cancer: a populationbased case-control study based on direct interview in Japan. J Gastroenterol. 2005;40:297-301.
13. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D. Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol. 2002;155:783-92.
14. Anderson LN, Cotterchio M, Gallinger S. Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada. Cancer Causes Control. 2009;20:825-34.
15. Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, Hayes RB, Swanson GM, Schoenberg JB, Pottern LM, Schwartz AG, Fraumeni Jr JF, et al. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst. 1998;90:1710-9.
16. Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, Bamlet WR, de Andrade M, Oberg AL, Hammer TJ, Rabe KG, Anderson KE, Olson JE, Sinha R, Petersen GM. Fruit and vegetable consumption is inversely associated with having pancreatic cancer. Cancer Causes Control. 2011;22:1613-25.
17. Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN, Petersen GM. Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16:1455-9.
18. Diet*Calc Analysis Program. Version 1.4.3: National Cancer Institute, Applied Research Program, November 2005. http://riskfactor.cancer. gov/DHQ/dietcalc/. Accessed Feb 2010.
19. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124:17-27.
20. SAS® software Version 9.2 of the SAS System for Unix ed. Version 9.2 Cary, NC, USA: Copyright © 9.2 SAS Institute Inc.: SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc., Cary, NC, USA.
21. Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, Lindahl B, Hallmans G, Kaaks R. Prospective study of hyperglycemia and cancer risk. Diabetes Care. 2007;30:561-7.
22. Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA. 2000;283:2552-8.
23. Stolzenberg-Solomon RZ, Graubard BI, Chari S, Limburg P, Taylor PR, Virtamo J, Albanes D. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA. 2005;294:2872-8.
24. McCarty MF. Insulin secretion as a determinant of pancreatic cancer risk. Med Hypotheses. 2001;57:146-50.
25. Michaud DS, Wolpin B, Giovannucci E, Liu S, Cochrane B, Manson JE, Pollak MN, Ma J, Fuchs CS. Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2007;16:2101-9.
26. Fisher WE, Boros LG, Schirmer WJ. Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. J Surg Res. 1996;63:310-3.
27. Kazakoff K, Cardesa T, Liu J, Adrian TE, Bagchi D, Bagchi M, Birt DF, Pour PM. Effects of voluntary physical exercise on highfat diet-promoted pancreatic carcinogenesis in the hamster model. Nutr Cancer. 1996;26:265-79.
28. Zagorsky JL. Health and wealth. The late-20th century obesity epidemic in the U.S. Econ Hum Biol. 2005;3:296-313.
29. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Hormone and metabolic research 0 Hormon-und Stoffwechselforschung 0 Hormones et metabolisme. Horm Metab Res. 2003;35:694-704.
30. Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, Hu FB. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care. 2004;27:134-40.
31. Guerrero-Romero F, Rodriguez-Moran M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord. 2002;26:469-74.
32. Balon TW, Gu JL, Tokuyama Y, Jasman AP, Nadler JL. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol. 1995;269:E745-52.
33. Song Y, Li TY, van Dam RM, Manson JE, Hu FB. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr. 2007;85:1068-74.
34. Paolisso G, Scheen A, Cozzolino D, Di Maro G, Varricchio M, D'Onofrio F, Lefebvre PJ. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab. 1994;78:1510-4.
35. Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003;26:1147-52.
36. Larsson SC, Wolk A. Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med. 2007;262:208-14.
37. Chan JM, Wang F, Holly EA. Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiol Biomarkers Prev. 2005;14:2093-7.
38. Stolzenberg-Solomon RZ, Sheffler-Collins S,Weinstein S,Garabrant DH, Mannisto S, Taylor P, Virtamo J, Albanes D. Vitamin E intake, alpha-tocopherol status, and pancreatic cancer in a cohort of male smokers. Am J Clin Nutr. 2009;89:584-91.
39. Reid-Lombardo KM, Fridley BL, Bamlet WR, Cunningham JM, Sarr MG, Petersen GM. Inflammation-related gene variants as risk factors for pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:1251-4.
40. Wheatley-Price P, Asomaning K, Reid A, Zhai R, Su L, Zhou W, Zhu A, Ryan DP, Christiani DC, Liu G. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer. 2008;112:1037-42.
41. Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab. 2006;50:85-94.
42. McCullough ML, Giovannucci EL. Diet and cancer prevention. Oncogene. 2004;23:6349-64.
43. Dauchet L, Peneau S, Bertrais S, Vergnaud AC, Estaquio C, Kesse-Guyot E, Czernichow S, Favier A, Faure H, Galan P, Hercberg S. Relationships between different types of fruit and vegetable consumption and serum concentrations of antioxidant vitamins. Br J Nutr. 2008;100:633-41.
44. Nkondjock A,Krewski D, Johnson KC, Ghadirian P. Dietary patterns and risk of pancreatic cancer. Int J Cancer. 2005;114:817-23.
45. Inoue M, Tajima K, Takezaki T, Hamajima N, Hirose K, Ito H, Tominaga S. Epidemiology of pancreatic cancer in Japan: a nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Int J Epidemiol. 2003;32:257-62.
46. Maritim AC, Sanders RA, Watkins 3rd JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24-38.
47. Cullen JJ, Mitros FA, Oberley LW. Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer. Pancreas. 2003;26:23-7.
48. Ough M, Lewis A, Zhang Y, Hinkhouse MM, Ritchie JM, Oberley LW, Cullen JJ. Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma. Free Radic Res. 2004;38:1223-33.